Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1966]

ASCO GU 2019 renal highlights

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma

Prof Brian Rini - Cleveland Clinic, Cleveland, USA

$Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )$

Sacituzumab govitecan in patients with previously treated metastatic urothelial...

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer

Dr Arjun Balar - NYU Langone Health, New York City, USA

Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )

BGICC 2019 ( )

When to increase and decrease burden of treatment for breast cancer patients

Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy

When to increase and decrease burden of treatment for breast cancer patients ( Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy )

APT for HER2 breast cancer patients with small tumours

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon

APT for HER2 breast cancer patients with small tumours ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )

Nivolumab in combination with CIMAvax-EGF for lung cancer

Dr Grace Dy - Roswell Park Cancer Institute, USA

Nivolumab in combination with CIMAvax-EGF for lung cancer ( Dr Grace Dy - Roswell Park Cancer Institute, USA )

Bispecific CD19/22 CAR therapy in children and young adults with ALL

Dr Liora M Schultz - Stanford University, Palo Alto, USA

Bispecific CD19/22 CAR therapy in children and young adults with ALL ( Dr Liora M Schultz - Stanford University, Palo Alto, USA )

Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent...

Dr Nicole Carreau - NYU Langone Health, New York, USA

Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent therapy ( Dr Nicole Carreau - NYU Langone Health, New York, USA )

Indoximod combined with chemotherapy in newly diagnosed AML patients

Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA

Indoximod combined with chemotherapy in newly diagnosed AML patients ( Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA )

Modulation of anti-tumour immunity using CDK4/6 inhibitors

Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA

Modulation of anti-tumour immunity using CDK4/6 inhibitors ( Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer